PAS
BLFS icon

Point72 Asia (Singapore)’s BioLife Solutions BLFS Stock Holding History

Point72 Asia (Singapore)’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$8.85K Buy
+347
New +$8.23K ﹤0.01% 787
2025
Q1 		– Sell
-1,194
Closed -$31K – 892
2024
Q4 		$31K Buy
+1,194
New +$29.7K 0.01% 596

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

Point72 Asia (Singapore)'s BLFS Position: Q3 2025 in Review

Point72 Asia (Singapore) opened a new position in BioLife Solutions (BLFS) in Q3 2025: 347 shares worth $8.85K. The stake represents ﹤0.01% of the portfolio and ranks #787 among its holdings. This is a return to the name: Point72 Asia (Singapore) previously reported a position in BLFS as recently as Q4 2024.

Point72 Asia (Singapore) first reported a position in BLFS in Q4 2024 and has held it in 2 quarters since. The position peaked at $31K in Q4 2024. 192 funds tracked by Wall St. Rank hold BLFS as of Q3 2025.

  • Point72 Asia (Singapore) held 347 shares of BioLife Solutions worth $8.85K as of Q3 2025.
  • BioLife Solutions was a new Point72 Asia (Singapore) position in Q3 2025.
  • BioLife Solutions made up ﹤0.01% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #787 holding.
  • Point72 Asia (Singapore) first reported a position in BioLife Solutions in Q4 2024 and has held it in 2 quarters since.
  • Point72 Asia (Singapore)'s BioLife Solutions position peaked at $31K in Q4 2024.
  • 192 funds tracked by Wall St. Rank held BioLife Solutions as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.